These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24649958)

  • 41. Recent advances in drug repositioning for the discovery of new anticancer drugs.
    Shim JS; Liu JO
    Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virtual screening of compound libraries.
    Cerqueira NM; Sousa SF; Fernandes PA; Ramos MJ
    Methods Mol Biol; 2009; 572():57-70. PubMed ID: 20694685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
    Don R; Ioset JR
    Parasitology; 2014 Jan; 141(1):140-6. PubMed ID: 23985066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.
    Shameer K; Readhead B; Dudley JT
    Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How to avoid rediscovering the known.
    Kuo LC
    Methods Enzymol; 2011; 493():159-68. PubMed ID: 21371591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical-pharmacological aspects to accelerate the development process from the preclinical to the clinical phase/1st communication: The contribution of clinical pharmacology].
    Kuhlmann J
    Arzneimittelforschung; 2004; 54(5):251-8. PubMed ID: 15212186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A survey of current trends in computational drug repositioning.
    Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
    Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel insight into drug repositioning: Methylthiouracil as a case in point.
    Baek MC; Jung B; Kang H; Lee HS; Bae JS
    Pharmacol Res; 2015 Sep; 99():185-93. PubMed ID: 26117428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. To screen or not to screen: an impassioned plea for smarter chemical libraries to improve drug lead finding.
    Lushington G; Chaguturu R
    Future Med Chem; 2014 Apr; 6(5):497-502. PubMed ID: 24649953
    [No Abstract]   [Full Text] [Related]  

  • 52. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
    Hennig M; Ruf A; Huber W
    Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Academic drug discovery in an age of research abundance, and the curious case of chemical screens toward drug repositioning.
    Datti A
    Drug Discov Today; 2023 May; 28(5):103522. PubMed ID: 36764576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data.
    Sawada R; Iwata H; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Dec; 55(12):2717-30. PubMed ID: 26580494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Confident application of a global human liver microsomal activity QSAR.
    Stålring J; Sohlenius-Sternbeck AK; Terelius Y; Parkes K
    Future Med Chem; 2018 Jul; 10(13):1575-1588. PubMed ID: 29953260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Literature mining, ontologies and information visualization for drug repurposing.
    Andronis C; Sharma A; Virvilis V; Deftereos S; Persidis A
    Brief Bioinform; 2011 Jul; 12(4):357-68. PubMed ID: 21712342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ask the experts: past, present and future of the rule of five.
    Baell J; Congreve M; Leeson P; Abad-Zapatero C
    Future Med Chem; 2013 May; 5(7):745-52. PubMed ID: 23651089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.